World Pharma Newsfeed
Takeda establishes new trading company and reinforces business structure in China
Takeda Pharmaceutical Company Limited ("Takeda") today announced the launch of a new trading company in China, Takeda (C...
Novartis makes progress in the fight to eliminate leprosy worldwide
Novartis celebrates the one-year anniversary of an unprecedented, coordinated effort to eliminate or control 10 neglecte...
Potential new treatment for gastrointestinal cancers discovered
Researchers have identified a complex of proteins that promotes the growth of some types of colon and gastric cancers, a...
Study of cancer cell metabolism yields new insights on leukemia
University of Rochester Medical Center scientists have proposed a new reason why acute myeloid leukemia, one of the most...
FDA approves new seasonal influenza vaccine made using novel technology
The U.S. Food and Drug Administration has approved Flublok, the first trivalent influenza vaccine made using an insect v...
FDA grants priority review to Boehringer Ingelheim's Afatinib* NDA for EGFR mutation-positive advanced NSCLC
Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afati...
Sanofi updates its Research & Development pipeline
Sanofi (EURONEXT: SAN and NYSE: SNY) has provided an update on its Research & Development (R&D) pipeline with Dr. Elias ...
Nations that consume a lot of milk... also win a lot of Nobel prizes
Nations that consume a lot of milk and milk products also tend to have a lot of Nobel laureates among their populations,...
Cancer suppressor gene links metabolism with cellular aging
It is perhaps impossible to overstate the importance of the tumor suppressor gene p53. It is the single most frequently ...
Phase III data show significant benefit of Novartis drug Afinitor® in patients with non-cancerous tumors associated with TSC
Data published in The Lancet showed that patients on Afinitor® (everolimus) tablets with non-cancerous kidney tumors kno...
